ReportsnReports.com: Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market
GBI Research, the leading business intelligence provider, has released its latest report, “Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market” which provides key data, information and analysis of the major trends and issues affecting the clinical trial market in Brazil. The report provides a comprehensive insight of the reasons for outsourcing clinical trials to Brazil and the key services provided by the Clinical Research...
View full press release